Research Vision

Mucosis strives to discover innovative mucosal vaccines that are more efficacious and user-friendly by translating excellent scientific research into a robust vaccine technology which we use to create better, painless and needle-free vaccines to combat viral, bacterial and parasitic pathogens. We are dedicated to achieving these goals by motivating talented researchers to excel and by collaborating with the best academic and industrial partners in the world.

research vision

19.05.15 Mucosis to Present Data on Intranasal RSV Vaccine SynGEM® at Modern Vaccines Adjuvants & Delivery Systems 2015
more >

23.03.15 Mucosis to Present on Intranasal Respiratory Syncytial Virus Vaccine Candidate SynGEM® at BioCapital Europe
more >

10.11.14 Mucosis Presents Data on Intranasal Respiratory Syncytial Virus Vaccine SynGEM® at RSV2014 Symposium
more >

20.10.14 Mucosis Presents Data on Intranasal RSV Vaccine SynGEM® at Vaccines 2014 Conference
more >

30.09.14 Mucosis Presents Infectious Diseases Vaccines Pipeline Update at SACHs Associates 14th Annual Biotech in Europe Forum
more >

22.05.14 Mucosis receives financial support from the Dutch government for its SynGEM® program
more >